Evaluation of the Efficacy and Safety of Two Doses of Aclidinium and Formoterol in Fixed-Dose Combination in Patients With COPD: The ACLIFORM Study

被引：6
|
作者：
Singh, Dave [1 ]
Jones, Paul [1 ]
Bateman, Eric [1 ]
Korn, Stephanie [1 ]
Serra, Cristina [1 ]
Molins, Eduard [1 ]
Caracta, Cynthia [1 ]
Gil, Esther Garcia [1 ]
Leselbaum, Anne [1 ]
机构：
[1] Univ S Manchester Hosp, Med Evaluat Unit, Manchester M20 8LR, Lancs, England
来源：
CHEST | 2014年 / 145卷 / 03期
关键词：
D O I：
10.1378/chest.1796046
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
375A
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
    D'Urzo, Anthony D.
    Singh, Dave
    Donohue, James F.
    Chapman, Kenneth R.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [22] Safety And Tolerability Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate: Results Of Two 6-Month Studies In Patients With Moderate To Severe COPD
    Make, B. J.
    D'Urzo, A. D.
    Jones, P. W.
    Mergel, V.
    Molins, E.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [23] Cardiovascular Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate: Results Of Two 6-Month Studies In Patients With Moderate To Severe COPD
    Donohue, J. F.
    D'Urzo, A. D.
    Singh, D.
    Mergel, V.
    Molins, E.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [24] Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
    Bateman, Eric D.
    Chapman, Kenneth R.
    Singh, Dave
    D'Urzo, Anthony D.
    Molins, Eduard
    Leselbaum, Anne
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2015, 16
  • [25] Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
    Eric D. Bateman
    Kenneth R. Chapman
    Dave Singh
    Anthony D. D’Urzo
    Eduard Molins
    Anne Leselbaum
    Esther Garcia Gil
    Respiratory Research, 16
  • [26] Lung Function And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Results Of A 1-Year Trial In Patients With COPD
    Make, B. J.
    Donohue, J. F.
    Soong, W.
    Zhong, X.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] Fixed-Dose Combination Of Aclidinium Bromide/formoterol Fumarate Improve Breathlessness And Health Status In COPD Patients: Augment COPD Trial
    Rennard, S. I.
    D'Urzo, A. D.
    Jones, P. W.
    Mergel, V.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [28] Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial
    Rennard, S. I.
    D'Urzo, A. D.
    Donohue, J. F.
    He, T.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [29] A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination
    Kilaru, Satish Chandra
    Bansal, Avya Gopal
    Naik, Vaishali Sandeep
    Lopez, Meena
    Gogtay, Jaideep Ashok
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (05) : 529 - 540
  • [30] Efficacy Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate On Bronchodilation Over 1 Year: Augment COPD Extension Trial In Patients With Moderate To Severe COPD
    D'Urzo, A. D.
    Rennard, S. I.
    Kerwin, E. M.
    He, T.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345